Update on the Diagnosis and Management of Familial Long QT Syndrome.

[1]  W. Zareba,et al.  Abstract 17128: Primary Prevention With Implantable Cardioverter Defibrillator in High-risk Long-QT Syndrome Patients , 2015 .

[2]  J. Skinner,et al.  Physical and Psychological Consequences of Left Cardiac Sympathetic Denervation in Long-QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia , 2015, Circulation. Arrhythmia and electrophysiology.

[3]  S. Middha,et al.  Homozygous/Compound Heterozygous Triadin Mutations Associated With Autosomal-Recessive Long-QT Syndrome and Pediatric Sudden Cardiac Arrest: Elucidation of the Triadin Knockout Syndrome , 2015, Circulation.

[4]  J. Skinner,et al.  Must every child with long QT syndrome take a beta blocker? , 2014, Archives of Disease in Childhood.

[5]  Derick R. Peterson,et al.  Efficacy of different beta-blockers in the treatment of long QT syndrome. , 2014, Journal of the American College of Cardiology.

[6]  Yingying Tang,et al.  Cardiac channelopathy testing in 274 ethnically diverse sudden unexplained deaths. , 2014, Forensic science international.

[7]  C. Tracy,et al.  HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. , 2013, Heart rhythm.

[8]  Thomas Meitinger,et al.  Calmodulin Mutations Associated With Recurrent Cardiac Arrest in Infants , 2013, Circulation.

[9]  Arthur A M Wilde,et al.  The ICD for Primary Prevention in Patients With Inherited Cardiac Diseases: Indications, Use, and Outcome: A Comparison With Secondary Prevention , 2013, Circulation. Arrhythmia and electrophysiology.

[10]  A. Shelling,et al.  Community detection of long QT syndrome with a clinical registry: an alternative to ECG screening programs? , 2013, Heart rhythm.

[11]  M. Ackerman,et al.  Return to play? Athletes with congenital long QT syndrome , 2012, British Journal of Sports Medicine.

[12]  R. Hauer,et al.  Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. , 2012, Journal of the American College of Cardiology.

[13]  R. Palmqvist,et al.  Iron-deficiency anaemia, gastric hyperplasia, and elevated gastrin levels due to potassium channel dysfunction in the Jervell and Lange-Nielsen Syndrome , 2012, Cardiology in the Young.

[14]  S. Seslar,et al.  Congenital long QT 3 in the pediatric population. , 2012, The American journal of cardiology.

[15]  Derick R. Peterson,et al.  Mutations in Cytoplasmic Loops of the KCNQ1 Channel and the Risk of Life-Threatening Events: Implications for Mutation-Specific Response to &bgr;-Blocker Therapy in Type 1 Long-QT Syndrome , 2012, Circulation.

[16]  Yolan J. Reckman,et al.  Variants in the 3′ untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner , 2011, European heart journal.

[17]  L. Yeates,et al.  The emerging role of the cardiac genetic counselor. , 2011, Heart rhythm.

[18]  P. Schwartz,et al.  QTc behavior during exercise and genetic testing for the long-QT syndrome. , 2011, Circulation.

[19]  J. Healey,et al.  Derivation and Validation of a Simple Exercise-Based Algorithm for Prediction of Genetic Testing in Relatives of LQTS Probands , 2011, Circulation.

[20]  A. Shelling,et al.  Symptoms and signs associated with syncope in young people with primary cardiac arrhythmias. , 2011, Heart, lung & circulation.

[21]  W. R. Berger,et al.  The QT and Corrected QT Interval in Recovery After Exercise in Children , 2011, Circulation. Arrhythmia and electrophysiology.

[22]  D. Tester,et al.  Genetic Testing for Potentially Lethal, Highly Treatable Inherited Cardiomyopathies/Channelopathies in Clinical Practice , 2011, Circulation.

[23]  A. Shelling,et al.  Prospective, population-based long QT molecular autopsy study of postmortem negative sudden death in 1 to 40 year olds. , 2011, Heart rhythm.

[24]  Michael J. Ackerman,et al.  Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. , 2011, Journal of the American College of Cardiology.

[25]  M. Ackerman,et al.  Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience. , 2010, Heart rhythm.

[26]  D. Tester,et al.  Prevalence and spectrum of large deletions or duplications in the major long QT syndrome-susceptibility genes and implications for long QT syndrome genetic testing. , 2010, The American journal of cardiology.

[27]  L. Jordaens,et al.  Who Are the Long-QT Syndrome Patients Who Receive an Implantable Cardioverter-Defibrillator and What Happens to Them?: Data From the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry , 2010, Circulation.

[28]  A. Moss,et al.  Beta‐Blocker Efficacy in High‐Risk Patients with the Congenital Long‐QT Syndrome Types 1 and 2: Implications for Patient Management , 2010, Journal of cardiovascular electrophysiology.

[29]  A. Skanes,et al.  Utility of the recovery electrocardiogram after exercise: a novel indicator for the diagnosis and genotyping of long QT syndrome? , 2010, Heart rhythm.

[30]  A. Wilde,et al.  The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. , 2010, Journal of the American College of Cardiology.

[31]  A. Moss,et al.  Risk of fatal arrhythmic events in long QT syndrome patients after syncope. , 2010, Journal of the American College of Cardiology.

[32]  Fabio Mosca,et al.  Prevalence of the Congenital Long-QT Syndrome , 2009, Circulation.

[33]  A. Shelling,et al.  Misdiagnosis of long QT syndrome as epilepsy at first presentation. , 2009, Annals of emergency medicine.

[34]  A. Wilde,et al.  Value of history-taking in syncope patients: in whom to suspect long QT syndrome? , 2009, Europace.

[35]  M. Ackerman,et al.  Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery. , 2009, Heart rhythm.

[36]  A. Massumi,et al.  Arrhythmogenicity of weight-loss supplements marketed on the Internet. , 2009, Heart rhythm.

[37]  S. Priori,et al.  High Efficacy of β-Blockers in Long-QT Syndrome Type 1: Contribution of Noncompliance and QT-Prolonging Drugs to the Occurrence of β-Blocker Treatment “Failures” , 2009, Circulation.

[38]  R. Beinart,et al.  Is Flecainide Dangerous in Long QT‐3 Patients? , 2009, Pacing and clinical electrophysiology : PACE.

[39]  A. Shelling,et al.  Identification of large gene deletions and duplications in KCNQ1 and KCNH2 in patients with long QT syndrome. , 2008, Heart rhythm.

[40]  W. Shimizu,et al.  Age‐ and Genotype‐Specific Triggers for Life‐Threatening Arrhythmia in the Genotyped Long QT Syndrome , 2008, Journal of cardiovascular electrophysiology.

[41]  E. Behr,et al.  Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. , 2008, European heart journal.

[42]  Arthur A M Wilde,et al.  Accurate electrocardiographic assessment of the QT interval: teach the tangent. , 2008, Heart rhythm.

[43]  E. Kaufman,et al.  Risk of death in the long QT syndrome when a sibling has died. , 2008, Heart rhythm.

[44]  Derick R. Peterson,et al.  Risk Factors for Aborted Cardiac Arrest and Sudden Cardiac Death in Children With the Congenital Long-QT Syndrome , 2008, Circulation.

[45]  E. Kaufman,et al.  Long QT syndrome and pregnancy. , 2007, Journal of the American College of Cardiology.

[46]  Derick R. Peterson,et al.  Long QT syndrome in adults. , 2007, Journal of the American College of Cardiology.

[47]  A. Moss,et al.  Corrected QT variability in serial electrocardiograms in long QT syndrome: the importance of the maximum corrected QT for risk stratification. , 2006, Journal of the American College of Cardiology.

[48]  G. Breithardt,et al.  Electrocardiographic risk stratification in families with congenital long QT syndrome. , 2006, European heart journal.

[49]  M. Lehmann,et al.  The long QT syndrome family of cardiac ion channelopathies: A HuGE review* , 2006, Genetics in Medicine.

[50]  Lauri Toivonen,et al.  The Jervell and Lange-Nielsen Syndrome: Natural History, Molecular Basis, and Clinical Outcome , 2006, Archives des maladies du coeur et des vaisseaux.

[51]  A. Wilde,et al.  Sudden Unexplained Death: Heritability and Diagnostic Yield of Cardiological and Genetic Examination in Surviving Relatives , 2005, Circulation.

[52]  G. Breithardt,et al.  Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: a long-term follow-up. , 2005, Heart rhythm.

[53]  S. Priori,et al.  Left Cardiac Sympathetic Denervation in the Management of High-Risk Patients Affected by the Long-QT Syndrome , 2004, Circulation.

[54]  J. Mason,et al.  A new oral therapy for long QT syndrome: long-term oral potassium improves repolarization in patients with HERG mutations. , 2003, Journal of the American College of Cardiology.

[55]  Calum A MacRae,et al.  Risk stratification in the long-QT syndrome. , 2003, The New England journal of medicine.

[56]  S. Viskin.  Implantable Cardioverter Defibrillator in High‐Risk Long QT Syndrome Patients , 2003, Journal of cardiovascular electrophysiology.

[57]  W. Allan,et al.  The long-QT syndrome. , 2000, The New England journal of medicine.

[58]  M. Viitasalo,et al.  Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. , 1999, Journal of the American College of Cardiology.

[59]  J. Towbin,et al.  Improvement of repolarization abnormalities by a K+ channel opener in the LQT1 form of congenital long-QT syndrome. , 1998, Circulation.

[60]  S. Priori,et al.  Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. , 1995, Circulation.

[61]  Peter J. Schwartz,et al.  Diagnostic Criteria for the Long QT Syndrome An Update , 1993, Circulation.

[62]  M. Leppert,et al.  The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. , 1992, The New England journal of medicine.

[63]  V. Cameron,et al.  Single nucleotide polymorphisms in arrhythmia genes modify the risk of cardiac events and sudden death in long QT syndrome. , 2014, Heart rhythm.

[64]  Hugues Abriel,et al.  Cardiac sodium channel Na(v)1.5 and interacting proteins: Physiology and pathophysiology. , 2010, Journal of molecular and cellular cardiology.

[65]  Carlo Napolitano,et al.  Erratum: Long QT syndrome patients with mutations on the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate: Implications for gene-specific therapy (Circulation (1995) 92 (3381-3386)) , 1996 .

[66]  G. Breithardt,et al.  Life-threatening Arrhythmias Genotype-phenotype Correlation in the Long-qt Syndrome : Gene-specific Triggers for Genotype-phenotype Correlation in the Long-qt Syndrome Gene-specific Triggers for Life-threatening Arrhythmias , 2022 .